Manish J. Dave, MD
- Hematology | Medical Oncology
I have an interest in clinical trials and the newest available targeted therapies. I have given multiple presentations and published numerous clinical and basic science research articles on both solid and hematologic malignancies. I have helped provide medical care to underserved residents of Winston-Salem, NC and Mumbai, India. Philosophy of Care StatementI treat both benign blood disorders and cancer, and I am devoted to providing compassionate care to my patients. My philosophy is to treat every patient as I would treat my own family member. I strive to provide the best and newest available therapy for my patients. |
Procedures:
Bone marrow aspirate & biopsy, intrathecal chemotherapy, lumbar puncture
Conditions:
Leukemia, lymphoma, multiple myeloma, lung cancer, prostate cancer, breast cancer, renal cancer, brain tumors, sarcoma, skin cancer, thyroid cancer, thymomas
Wake Forest University School of Medicine
-
2011
NC
Rush University Medical Center
-
2012
Rush University Medical Center
-
2014
Albert Einstein College of Medicine
-
2017
Title: | The effect of deep brain stimulation on voiding dysfunction in Parkinson’s Disease and essential tremor. |
Authors: | Vishwajit S, Dave M, Case D, Siddiqui M, Badlani G. |
Publisher: | The Journal of Urology |
Date: | 2009 |
Issue: | Apr; 181(4): 673-674. |
Description: |
Title: | Treatment of Recurrent Pediatric Gastrointestinal Stromal Tumors. |
Authors: | Dave M, Jimenez A, Evans K, Leslie W. |
Publisher: | Gastrointestinal Cancer Research. |
Date: | 2012 |
Issue: | Jul-Aug; 5(4): 139–140. |
Description: |
Title: | EGFR gene mutation and epithelial to mesenchymal transition (EMT) markers in advanced NSCLC patients treated with erlotinib. |
Authors: | Fidler MJ, Dave M, Basu S, Hensing TA, Pool M, Mahon B, Borgia JA, Walters KK, Escarzaga D, Batus M, Bonomi PD. |
Publisher: | J Clin Oncol |
Date: | 2012 |
Issue: | suppl; abstr e18117 |
Description: |
Title: | The effect of BMI on systemic toxicity in AML patients receiving chemotherapy. |
Authors: | Dave M, Burhani M, Venugopal P, Larson M. |
Publisher: | J Clin Oncol |
Date: | 2013 |
Issue: | suppl; abstr 7108 |
Description: |
Title: | Influence of BMI on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML. |
Authors: | Burhani M, Dave M, Venugopal P, Larson M. |
Publisher: | J Clin Oncol |
Date: | 2013 |
Issue: | suppl; abstr 7106 |
Description: |
Title: | Classical Hodgkin’s Lymphoma Presenting with Hemophagocytosis. |
Authors: | Dave M, Khedimi R, Averbukh Y. |
Publisher: | MOJ Auto Dis |
Date: | |
Issue: | 1(1): 00002. |
Description: |
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.